Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D

被引:50
|
作者
Whitesitt, CA
Simon, RL
Reel, JK
Sigmund, SK
Phillips, ML
Shadle, JK
Heinz, LJ
Koppel, GA
Hunden, DC
Lifer, SL
Berry, D
Ray, J
Little, SP
Liu, XD
Marshall, WS
Panetta, JA
机构
[1] Lilly Research Laboratories, Eli Lilly and Company, Indianapolis
关键词
D O I
10.1016/0960-894X(96)00393-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non peptide inhibitors of cathepsin D, an aspartyl protease that has been implicated in many disease states including Alzheimer's disease, were prepared and evaluated. The most potent inhibitor of cathepsin D in this series was found to be (Z)-5-[[4-(4-benzoyl-3-hydroxy-2-propylphenoxy)methylphenyl]methylene]-2-thioxo-4-thiazolidinone (3f, IC50 = 210 nM). Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:2157 / 2162
页数:6
相关论文
共 50 条
  • [1] Design, synthesis and structure-activity relationships of carbohydrazide based cathepsin K inhibitors
    Thompson, SK
    Tomaszek, TA
    Tew, DG
    Levy, MA
    Smith, WW
    Zhao, B
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    DesJarlais, RL
    Abdel-Meguid, SS
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U287 - U287
  • [2] Non-thiol farnesyltransferase inhibitors: Structure-activity relationships of aralkylsubsituted benzophenones
    Mitsch, A
    Wissner, P
    Sattler, I
    Schlitzer, M
    ARCHIV DER PHARMAZIE, 2001, 334 (02) : 40 - 44
  • [3] Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors
    Dumas, J
    Brittelli, D
    Chen, JS
    Dixon, B
    Hatoum-Mokdad, H
    König, G
    Sibley, R
    Witowsky, J
    Wong, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) : 2531 - 2536
  • [4] Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D
    Bravo-Altamirano, Karla
    George, Kara M.
    Frantz, Marie-Celine
    LaValle, Courtney R.
    Tandon, Manuj
    Leimgruber, Stephanie
    Sharlow, Elizabeth R.
    Lazo, John S.
    Wang, Q. Jane
    Wipf, Peter
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (02): : 154 - 159
  • [5] Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X
    Fonovic, Ursa Pecar
    Knez, Damijan
    Hrast, Martina
    Zidar, Nace
    Proj, Matic
    Gobec, Stanislav
    Kos, Janko
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
  • [6] Inhibitors of vitamin D hydroxylases: Structure-activity relationships
    Schuster, I
    Egger, H
    Nussbaumer, P
    Kroemer, RT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 372 - 380
  • [7] Selective and reversible cathepsin X inhibitors: development and structure-activity relationships study
    Fonovic, U. Pecar
    Knez, D.
    Hrast, M.
    Mitrovic, A.
    Pislar, A.
    Zidar, N.
    Proj, M.
    Jakos, T.
    Stojan, J.
    Zakelj, S.
    Trontelj, J.
    Brus, B.
    Gobec, S.
    Kos, J.
    FEBS OPEN BIO, 2021, 11 : 166 - 166
  • [8] STRUCTURE-ACTIVITY RELATIONSHIPS OF A VECTORIZED CATHEPSIN D INHIBITOR, A POTENTIAL ANTIPROLIFERATIVE AGENT
    Sanchez, C.
    Maynadier, M.
    Martin, V.
    Vezenkov, L. L.
    Bellet, V.
    Garcia, M.
    Martinez, J.
    Amblard, M.
    Lisowski, V.
    Hernandez, J-F.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S174 - S174
  • [9] Isolation, synthesis and structure-activity relationships of gallotannin derivatives as cathepsin C inhibitor
    Liao, Hung-Chen
    Kuo, Liang-Mou
    Chen, Wei-Ting
    Huang, Yu-Ling
    Sethy, Bidyadhar
    Dhandabani, Ganesh Kumar
    Hsieh, Pei-Wen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 120
  • [10] Cysteine derivatives as inhibitors for carboxypeptidase A: Synthesis and structure-activity relationships
    Park, JD
    Kim, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 911 - 918